Sio Capital Management’s Ovid Therapeutics OVID Stock Holding History

Sio Capital Management’s Portfolio OVID Stock Details OVID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.78M	Sell	1,252,381 -175,114	-12%	-$313K	0.4%	51
2025 Q4	$2.33M	Hold	1,427,495	–	–	0.37%	48
2025 Q3	$1.86M	Sell	1,427,495 -804,505	-36%	-$697K	0.47%	37
2025 Q2	$736K	Hold	2,232,000	–	–	0.28%	40
2025 Q1	$696K	Buy	2,232,000 +1,232,000	+123%	+$758K	0.21%	44
2024 Q4	$934K	Buy	+1,000,000	New	+$1.12M	0.26%	38
2020 Q1	–	Sell	-264,581	Closed	-$1.1M	–	83
2019 Q4	$1.1M	Buy	+264,581	New	+$835K	0.26%	58

Other funds holding OVID

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Sio Capital Management's OVID Position: Q1 2026 in Review

Sio Capital Management reduced its Ovid Therapeutics (OVID) stake by 12% in Q1 2026, selling an estimated $313K and leaving 1,252,381 shares worth $2.78M. The position accounts for 0.4% of the portfolio, ranked #51.

Sio Capital Management first reported a position in OVID in Q4 2019 and has held it in 7 quarters since. 103 funds tracked by Wall St. Rank hold OVID as of Q1 2026.

Sio Capital Management held 1,252,381 shares of Ovid Therapeutics worth $2.78M as of Q1 2026.
Sio Capital Management sold 175,114 Ovid Therapeutics shares in Q1 2026, an estimated $313K.
Ovid Therapeutics made up 0.4% of Sio Capital Management's portfolio in Q1 2026, its #51 holding.
Sio Capital Management first reported a position in Ovid Therapeutics in Q4 2019 and has held it in 7 quarters since.
103 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2026.

Based on Sio Capital Management's 13F filing for Q1 2026, filed 14 May 2026.